ROCHESTER, N.Y., May 1, 2014 /PRNewswire/ -- VirtualScopics,
Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging
solutions, today announced it will report its first quarter 2014
financial results before the market opens on Thursday, May 15, 2014. Eric Converse, interim chief executive officer,
and Jim Groff, acting chief
financial officer, will host a conference call to discuss the
company's financial results and provide a business update at
8:30 a.m. ET that morning.
Conference call and replay information is as
follows:
Domestic Call Dial In: 877-407-8035
International Call Dial In: 201-689-8035
Conference Call ID: 13581706
An accompanying slide presentation to enhance managements'
formal remarks, as well as a webcast of the call, can be accessed
at http://www.virtualscopics.com/webcasts.aspx.
A replay and slide presentation will be available one hour after
the conclusion of the conference call for 90 days, and can be
accessed accordingly:
Replay Domestic Dial In: 877-660-6853
Replay International Dial In: 201-612-7415
Replay Conference Call ID: 13581706
Webcast and slide presentation:
http://www.virtualscopics.com/webcasts.aspx.
About VirtualScopics, Inc.
VirtualScopics, Inc.
(NASDAQ:VSCP) is a leading provider of quantitative imaging
solutions to accelerate drug and medical device development.
For risk-adverse, time-constrained Clinical Trial Study Teams,
Medical Directors and Imaging Scientists who require quality
imaging data delivered on-time, within budget and on a consistent
basis, VirtualScopics' clinical trial imaging solutions are an
inspired true exception to commonly accepted services provided by
other clinical trial imaging providers. Because of the
scientific and operational flexibility and responsiveness they can
offer, VirtualScopics' clinical trial imaging solutions deliver
special performance advantages compared to other image service
providers that offer common, every day clinical trial imaging
services. For more information about VirtualScopics, Inc.
please visit www.virtualscopics.com.
For more information, contact:
Donna N. Stein, APR, Fellow PRSA
Managing Partner, Donna Stein &
Partners
315-361-4672
dstein1@twcny.rr.com
SOURCE VirtualScopics, Inc.